Because of the increased risk of
hypermagnesaemia, the European
Medicines Agency has suspended
the marketing authorisation of
intravenous nutritional solution
Numeta G13%E for children with
ingestion problems; Numeta G16%E
has not been suspended.
For more details CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Sep 13
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.